Showing 1 - 6 results of 6 for search 'Emrullah Yilmaz', query time: 0.03s Refine Results
  1. 1
    462 Single agent immunotherapy response in patients with head and neck squamous cell carcinoma with prior history of radiation therapy

    462 Single agent immunotherapy response in patients with head and neck squamous cell carcinoma with prior history of radiation therapy by David Lee, Emrullah Yilmaz, Moises Harari-Turquie, Shashank Cingam, Gregory Gan

    Published 2020-11-01
    Article
  2. 2
    Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity

    Role of molecular signature to differentiate second primary lung cancer from metastasis in a patient with squamous cell carcinoma of oral cavity by Emrullah Yilmaz, Gregory N. Gan, Thomas M. Schroeder, Andrew Cowan, Nancy Joste

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Intravascular squamous cell carcinoma treated with cemiplimab

    Intravascular squamous cell carcinoma treated with cemiplimab by Alexander N. Rose, BS, Emrullah Yilmaz, MD, PhD, John R. Durkin, MD

    Published 2021-08-01
    Get full text
    Article
  4. 4
    MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.

    MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors. by Adrian J Luna, Rosa T Sterk, Anastacia M Griego-Fisher, Joon-Yong Chung, Kiersten L Berggren, Virginie Bondu, Pamela Barraza-Flores, Andrew T Cowan, Gregory N Gan, Emrullah Yilmaz, Hanbyoul Cho, Jae-Hoon Kim, Stephen M Hewitt, Julie E Bauman, Michelle A Ozbun

    Published 2021-01-01
    Get full text
    Article
  5. 5
    NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer

    NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer by Julie E. Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L. Ferris, Josephine Chen, Richard C. Jordan, Nikhil P. Joshi, Srinivas Jujjuvaparu, Dukagjin M. Blakaj, Christina Henson, Jawad Sheqwara, Loren K. Mell, Neilayan Sen, David A. Clump, Madhur K. Garg, Emrullah Yilmaz, Pedro Torres-Saavedra, Quynh-Thu Le

    Published 2021-06-01
    Get full text
    Article
  6. 6
    Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept

    Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept by Hanna Hong, Chase J. Wehrle, Mingyi Zhang, Sami Fares, Henry Stitzel, David Garib, Bassam Estfan, Suneel Kamath, Smitha Krishnamurthi, Wen Wee Ma, Teodora Kuzmanovic, Elizabeth Azzato, Emrullah Yilmaz, Jamak Modaresi Esfeh, Maureen Whitsett Linganna, Mazhar Khalil, Alejandro Pita, Andrea Schlegel, Jaekeun Kim, R. Matthew Walsh, Charles Miller, Koji Hashimoto, David Choon Hyuck Kwon, Federico Aucejo

    Published 2024-02-01
    Get full text
    Article

Search Tools: